FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
1970-01-01 08:00
US FDA approves Regeneron's 8-mg dose of eye disease drug Eylea
The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron Pharmaceuticals' eye disease drug Eylea, the
1970-01-01 08:00
Nvidia invests $50 million in Recursion to train AI models for drug discovery
(Reuters) -Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which
1970-01-01 08:00